Understanding the Multilevel Drivers of Liver Cancer Disparities

了解肝癌差异的多层次驱动因素

基本信息

项目摘要

Project Summary/Abstract From 2000-2014, hepatocellular carcinoma, or HCC, incidence rates increased nearly 4% per year, while most cancers in the United States were on the decline. HCC disproportionately impacts minority racial/ethnic groups who are diagnosed at rates approximately twice that of non-Hispanic Whites. To inform primary prevention strategies that will reduce disparities in HCC risk, we need to determine the relative contribution of well- established and emerging (e.g., hepatitis B virus, hepatitis C virus, alcohol, smoking, cirrhosis, NAFLD, metabolic disorders, diabetes, HIV infection), and novel (e.g., medications, comorbidities, neighborhood attributes) risk factors to these disparities. To inform secondary and tertiary prevention strategies to reduce disparities in HCC burden, we need to understand the multilevel factors that contribute to HCC surveillance disparities. Answering these gaps in knowledge requires a robust high-quality study with a sample enriched for racial/ethnic minorities. Thus, we propose to leverage existing multi-disciplinary collaborations to develop an integrated dataset that includes electronic health records (EHR) data linked to population-based state cancer registry data and geospatial contextual data. This multilevel resource will include data on nearly 2.3 million individuals from three healthcare systems (mixed payer, integrated healthcare, federally qualified health centers) in California and Hawaii, thus providing diversity in healthcare settings and enrichment for racial/ethnic minorities: 59,400 are Black, 189,500 are Hispanic, and 441,700 are Asian American/Native Hawaiian/Pacific Islander (AANHPI). With this resource, we specifically aim to: (1) assess the relative importance of established and emerging examine the extent to which these factors independently and jointly contribute to racial/ethnic disparities in HCC risk; (2) discover novel risk factors and assess their relative importance to HCC risk; and (3) assess racial/ethnic disparities in adherence with surveillance for HCC as well as examine the extent to which these disparities are attributable to modifiable individual-, clinician-, system-, and neighborhood factors (Aim 3). For Aim 1, using prospective data, we will assess the relative importance of risk factors and their contribution to racial/ethnic disparities in HCC risk with causal inference methods. For Aim 2, we will apply innovative machine learning methods to identify novel factors and validate their associations with HCC risk using modeling strategy from Aim 1. For Aim 3, we will use multilevel generalized linear regression to investigate the patient, clinician, institutional and geographic factors that contribute to disparities in HCC surveillance. Given the importance of sex and age/birth cohort for HCC risk, these social determinants will be considered together with race/ethnicity using an intersectional approach. By applying a multilevel framework to understand how biological, clinical, and social factors at multiple levels contribute to HCC disparities in incidence and surveillance, the proposed study will identify modifiable factors that can be translated to the clinical and community settings to collaboratively identify strategies to ameliorate racial/ethnic disparities in HCC.
项目总结/摘要 从2000年到2014年,肝细胞癌(HCC)的发病率每年增加近4%,而大多数人的发病率每年都在增加。 美国的癌症发病率在下降。HCC不成比例地影响少数种族/族裔群体 他们的确诊率大约是非西班牙裔白人的两倍。为初级预防提供信息 为了减少HCC风险的差异,我们需要确定良好的相对贡献, 已建立的和新兴的(例如,B型肝炎病毒、C型肝炎病毒、酒精、吸烟、肝硬化、NAFLD, 代谢紊乱、糖尿病、HIV感染),和新的(例如,药物、合并症、邻居 这些差异的风险因素。为二级和三级预防战略提供信息, 肝癌负担的差异,我们需要了解有助于肝癌监测的多层次因素 差距。填补这些知识空白需要一项强有力的高质量研究, 种族/少数民族。因此,我们建议利用现有的多学科合作, 一个综合数据集,包括与基于人群的状态癌症相关的电子健康记录(EHR)数据 登记册数据和地理空间背景数据。这个多层次的资源将包括近230万的数据 来自三个医疗保健系统的个人(混合支付者、综合医疗保健、联邦合格医疗保健) 在加州和夏威夷的中心),从而提供医疗保健设置的多样性和丰富的种族/民族 少数民族:59,400人是黑人,189,500人是西班牙裔,441,700人是亚裔美国人/夏威夷原住民/太平洋裔 岛民(AANHPI)。有了这个资源,我们的具体目标是:(1)评估建立的相对重要性 和新兴的研究在多大程度上这些因素独立和共同有助于种族/族裔 HCC风险的差异;(2)发现新的风险因素并评估其对HCC风险的相对重要性;以及(3) 评估坚持HCC监测的种族/民族差异,并检查 这些差异可归因于可改变的个体、临床医生、系统和邻近因素(目标3)。 对于目标1,使用前瞻性数据,我们将评估风险因素的相对重要性及其贡献 用因果推理方法对HCC风险中的种族/民族差异进行分析。对于目标2,我们将采用创新的 使用机器学习方法识别新因素并验证其与HCC风险的关联, 目标1的建模策略。对于目标3,我们将使用多水平广义线性回归来研究 患者、临床医生、机构和地理因素导致HCC监测的差异。给定 性别和年龄/出生队列对HCC风险的重要性,这些社会决定因素将被一起考虑 种族/民族使用交叉的方法。通过应用多层次框架来理解 多个层面的生物学、临床和社会因素导致HCC发病率的差异, 监测,拟议的研究将确定可改变的因素,可以转化为临床和 社区环境,以合作确定战略,以改善HCC中的种族/民族差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Salma Shariff-Marco其他文献

Salma Shariff-Marco的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Salma Shariff-Marco', 18)}}的其他基金

Understanding the Multilevel Drivers of Liver Cancer Disparities
了解肝癌差异的多层次驱动因素
  • 批准号:
    10215436
  • 财政年份:
    2019
  • 资助金额:
    $ 64.03万
  • 项目类别:
Elucidating individual and neighborhood factors associated with nonalcoholic fatty liver disease (NAFLD)
阐明与非酒精性脂肪肝(NAFLD)相关的个人和社区因素
  • 批准号:
    10381399
  • 财政年份:
    2019
  • 资助金额:
    $ 64.03万
  • 项目类别:
Understanding the Multilevel Drivers of Liver Cancer Disparities
了解肝癌差异的多层次驱动因素
  • 批准号:
    10671556
  • 财政年份:
    2019
  • 资助金额:
    $ 64.03万
  • 项目类别:
Understanding the Multilevel Drivers of Liver Cancer Disparities
了解肝癌差异的多层次驱动因素
  • 批准号:
    10524105
  • 财政年份:
    2019
  • 资助金额:
    $ 64.03万
  • 项目类别:
Impact of social and built environments on health-related quality of life for cancer survivors
社会和建筑环境对癌症幸存者健康相关生活质量的影响
  • 批准号:
    9673640
  • 财政年份:
    2018
  • 资助金额:
    $ 64.03万
  • 项目类别:
Impact of social and built environments on health-related quality of life for cancer survivors
社会和建筑环境对癌症幸存者健康相关生活质量的影响
  • 批准号:
    9024189
  • 财政年份:
    2016
  • 资助金额:
    $ 64.03万
  • 项目类别:
Developing Neighborhood Archetypes for Understanding Disparities in Cancer
开发社区原型以了解癌症的差异
  • 批准号:
    8604276
  • 财政年份:
    2014
  • 资助金额:
    $ 64.03万
  • 项目类别:
Developing Neighborhood Archetypes for Understanding Disparities in Cancer
开发社区原型以了解癌症的差异
  • 批准号:
    8928061
  • 财政年份:
    2014
  • 资助金额:
    $ 64.03万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 64.03万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了